levodopa has been researched along with Cacosmia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, R; Crespo Cuevas, AM; De Haro, J; Isern, I; Ispierto, L; Planas, A; Sanchez, J; Vilas, D | 1 |
| Cova, I; Priori, A | 1 |
| Chen, H; Huang, X; Kong, L; Lee, EY; Lewis, MM; Lucassen, EB; Sterling, NW | 1 |
| Duan, SJ; Han, B; Lu, Y; Wang, LJ; Wang, SY; Wang, T; Zhu, Q | 1 |
| Habersack, A; Haehner, A; Hummel, T; Reichmann, H; Storch, A; Wienecke, M | 1 |
| Burkhard, PR; Landis, BN | 1 |
| Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D | 1 |
| Adeleine, P; Broussolle, E; Hudry, J; Royet, JP; Thobois, S | 1 |
| Turnbull, C | 1 |
| Ahlskog, JE | 1 |
| Amick, MM; Chou, KL; Friedman, JH | 1 |
| Neundörfer, B; Valdivieso, T | 1 |
| Andre, JM; Kissel, P | 1 |
| Ansari, KA; Johnson, A | 1 |
3 review(s) available for levodopa and Cacosmia
| Article | Year |
|---|---|
Diagnostic biomarkers for Parkinson's disease at a glance: where are we?
Topics: alpha-Synuclein; Biomarkers; Brain; Cognition Disorders; Constipation; Depression; Early Diagnosis; Genetic Predisposition to Disease; Humans; Inflammation; Levodopa; Metabolomics; Microbiota; Movement Disorders; Neuroimaging; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Symptom Assessment; Vision Disorders | 2018 |
Treatment of early Parkinson's disease. Part 2.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors | 2009 |
Beating a dead horse: dopamine and Parkinson disease.
Topics: Animals; Antiparkinson Agents; Brain; Brain Tissue Transplantation; Constipation; Deep Brain Stimulation; Dopamine; Humans; Levodopa; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder | 2007 |
11 other study(ies) available for levodopa and Cacosmia
| Article | Year |
|---|---|
Distinctive Olfactory Pattern in Parkinson's Disease and Non-Neurodegenerative Causes of Hyposmia.
Topics: Aged; Aged, 80 and over; Agnosia; Brain Injuries, Traumatic; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Smell | 2018 |
History of smoking and olfaction in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Monoamine Oxidase Inhibitors; Olfaction Disorders; Parkinson Disease; Smell; Smoking | 2014 |
Coadministration of hydroxysafflor yellow A with levodopa attenuates the dyskinesia.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Apomorphine; Chalcone; Disease Models, Animal; Levodopa; Male; Motor Activity; Olfaction Disorders; Oxidopamine; Parkinson Disease; Quinones; Rats; Receptors, Dopamine D3; Time Factors | 2015 |
Early Parkinson's disease patients on rasagiline present with better odor discrimination.
Topics: Antiparkinson Agents; Cross-Sectional Studies; Discrimination, Psychological; Female; Humans; Indans; Levodopa; Male; Middle Aged; Neuroprotective Agents; Odorants; Olfaction Disorders; Olfactory Perception; Parkinson Disease; Physical Stimulation; Prospective Studies; Psychophysics; Sensory Thresholds; Severity of Illness Index; Treatment Outcome | 2015 |
Rhinorrhea and olfaction in Parkinson disease.
Topics: Age Distribution; Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Comorbidity; Female; Humans; Levodopa; Male; Middle Aged; Nasal Mucosa; Olfaction Disorders; Parasympathetic Fibers, Postganglionic; Parkinson Disease; Prevalence; Rhinitis; Sex Distribution; Sympathetic Fibers, Postganglionic | 2008 |
Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease.
Topics: Age Factors; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Odorants; Olfaction Disorders; Parkinson Disease; Perception; Semantics; Sensory Thresholds; Smell; Task Performance and Analysis | 2003 |
Vascular parkinsonism--an important update.
Topics: Antiparkinson Agents; Diagnosis, Differential; Diagnostic Imaging; Humans; Intracranial Arteriosclerosis; Levodopa; Neurologic Examination; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Parkinson Disease, Secondary; Sensitivity and Specificity | 2005 |
Rhinorrhea and olfaction in Parkinson disease.
Topics: Age Distribution; Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Comorbidity; Female; Humans; Levodopa; Male; Middle Aged; Nasal Mucosa; Olfaction Disorders; Parasympathetic Fibers, Postganglionic; Parkinson Disease; Prevalence; Rhinitis; Sex Distribution; Sympathetic Fibers, Postganglionic | 2008 |
[Parosmia and anosmia under L-dopa therapy (author's transl)].
Topics: Carboxy-Lyases; Humans; Levodopa; Male; Middle Aged; Olfaction Disorders; Parkinson Disease, Secondary; Smell; Time Factors | 1977 |
[Parkinson's disease and anosmia in monozygotic twin sisters (author's transl)].
Topics: Adult; Diseases in Twins; Dopamine; Female; Humans; Levodopa; Olfaction Disorders; Parkinson Disease; Pedigree; Pregnancy; Twins, Monozygotic | 1976 |
Olfactory function in patients with Parkinson's disease.
Topics: Adult; Aged; Differential Threshold; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Olfaction Disorders; Olfactory Bulb; Parkinson Disease; Smoking | 1975 |